1,530
Views
2
CrossRef citations to date
0
Altmetric
Review

Copper coordination modulates prion conversion and infectivity in mammalian prion proteins

ORCID Icon
Pages 1-6 | Received 07 Oct 2022, Accepted 22 Dec 2022, Published online: 03 Jan 2023

References

  • Legname G. Elucidating the function of the prion protein. PLoS Pathog. 2017 Aug;13(8):e1006458.
  • Prusiner SB. Biology and genetics of prions causing neurodegeneration. Annu Rev Genet. 2013;47:601–623.
  • Prusiner SB. Cell biology. A unifying role for prions in neurodegenerative diseases. Science. 2012 Jun 22;336(6088):1511–1513.
  • Scialo C, Legname G. The role of the cellular prion protein in the uptake and toxic signaling of pathological neurodegenerative aggregates. Prog Mol Biol Transl Sci. 2020;175:297–323.
  • Aulic S, Masperone L, Narkiewicz J, et al. alpha-synuclein amyloids hijack prion protein to gain cell entry, facilitate cell-to-cell spreading and block prion replication. Sci Rep. 2017 Aug 30;7(1):10050.
  • De Cecco E, Celauro L, Vanni S, et al. The uptake of tau amyloid fibrils is facilitated by the cellular prion protein and hampers prion propagation in cultured cells. J Neurochem. 2020 Dec;155(5):577–591.
  • Scialo C, Celauro L, Zattoni M, et al. The cellular prion protein increases the uptake and toxicity of TDP-43 fibrils. Viruses. 2021 Aug 17;13(8):1625.
  • Gasperini L, Meneghetti E, Pastore B, et al. Prion protein and copper cooperatively protect neurons by modulating NMDA receptor through S-nitrosylation. Antioxid Redox Signal. 2015 Mar 20;22(9):772–784.
  • Amin L, Nguyen XT, Rolle IG, et al. Characterization of prion protein function by focal neurite stimulation. J Cell Sci. 2016 Oct 15;129(20):3878–3891.
  • Caiati MD, Safiulina VF, Fattorini G, et al. PrPC controls via protein kinase A the direction of synaptic plasticity in the immature hippocampus. J Neurosci. 2013 Feb 13;33(7):2973–2983.
  • Biljan I, Ilc G, Giachin G, et al. NMR structural studies of human cellular prion proteins. Curr Top Med Chem. 2013;13(19):2407–2418.
  • Viles JH, Cohen FE, Prusiner SB, et al. Copper binding to the prion protein: structural implications of four identical cooperative binding sites. Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2042–2047.
  • Burns CS, Aronoff-Spencer E, Dunham CM, et al. Molecular features of the copper binding sites in the octarepeat domain of the prion protein. Biochemistry. 2002 Mar 26;41(12):3991–4001.
  • Millhauser GL. Copper binding in the prion protein. Acc Chem Res. 2004 Feb;37(2):79–85.
  • Burns CS, Aronoff-Spencer E, Legname G, et al. Copper coordination in the full-length, recombinant prion protein. Biochemistry. 2003 Jun 10;42(22):6794–6803.
  • Abskharon RN, Giachin G, Wohlkonig A, et al. Probing the N-terminal beta-sheet conversion in the crystal structure of the human prion protein bound to a nanobody. J Am Chem Soc. 2014 Jan 22;136(3):937–944.
  • Nakic N, Tran TH, Novokmet M, et al. Site-specific analysis of N-glycans from different sheep prion strains. PLoS Pathog. 2021 Feb;17(2):e1009232.
  • Brown DR, Qin K, Herms JW, et al. The cellular prion protein binds copper in vivo. Nature. 1997 Dec 18-25;390(6661):684–687.
  • Stockel J, Safar J, Wallace AC, et al. Prion protein selectively binds copper(II) ions. Biochemistry. 1998 May 19;37(20):7185–7193.
  • Aronoff-Spencer E, Burns CS, Avdievich NI, et al. Identification of the Cu2+ binding sites in the N-terminal domain of the prion protein by EPR and CD spectroscopy. Biochemistry. 2000 Nov 14;39(45):13760–13771.
  • Posadas Y, Lopez-Guerrero VE, Segovia J, et al. Dissecting the copper bioinorganic chemistry of the functional and pathological roles of the prion protein: relevance in Alzheimer’s disease and cancer. Curr Opin Chem Biol. 2022 Feb;66:102098.
  • Nguyen XTA, Tran TH, Cojoc D, et al. Copper binding regulates cellular prion protein function. Mol Neurobiol. 2019 Sep;56(9):6121–6133.
  • Sigurdsson EM, Brown DR, Alim MA, et al. Copper chelation delays the onset of prion disease. J Biol Chem. 2003 Nov 21;278(47):46199–46202.
  • Bocharova OV, Breydo L, Salnikov VV, et al. Copper(II) inhibits in vitro conversion of prion protein into amyloid fibrils. Biochemistry. 2005 May 10;44(18):6776–6787.
  • Delisle MB, Uro-Coste E, Gray F, et al. Fatal familial insomnia. Clin Exp Pathol. 1999;47(3–4):176–180.
  • Hokfelt T, Broberger C, Zhang X, et al. Neuropeptide Y: some viewpoints on a multifaceted peptide in the normal and diseased nervous system. Brain Res Brain Res Rev. 1998 May;26(2–3):154–166.
  • Norstrom EM, Mastrianni JA. The AGAAAAGA palindrome in PrP is required to generate a productive PrPSc-PrPC complex that leads to prion propagation. J Biol Chem. 2005 Jul 22;280(29):27236–27243.
  • Lau A, McDonald A, Daude N, et al. Octarepeat region flexibility impacts prion function, endoproteolysis and disease manifestation. EMBO Mol Med. 2015 Mar;7(3):339–356.
  • Eigenbrod S, Frick P, Bertsch U, et al. Substitutions of PrP N-terminal histidine residues modulate scrapie disease pathogenesis and incubation time in transgenic mice. PLoS One. 2017;12(12):e0188989.
  • Abskharon R, Wang F, Wohlkonig A, et al. Structural evidence for the critical role of the prion protein hydrophobic region in forming an infectious prion. PLoS Pathog. 2019 Dec;15(12):e1008139.
  • Legname G, Baskakov IV, Nguyen HO, et al. Synthetic mammalian prions. Science. 2004 Jul 30;305(5684):673–676.
  • Flechsig E, Shmerling D, Hegyi I, et al. Prion protein devoid of the octapeptide repeat region restores susceptibility to scrapie in PrP knockout mice. Neuron. 2000 Aug;27(2):399–408.
  • Shmerling D, Hegyi I, Fischer M, et al. Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions. Cell. 1998 Apr 17;93(2):203–214.
  • Ghetti B, Dlouhy SR, Giaccone G, et al. Gerstmann-Straussler-Scheinker disease and the Indiana kindred. Brain Pathol. 1995 Jan;5(1):61–75.
  • Stevens DJ, Walter ED, Rodriguez A, et al. Early onset prion disease from octarepeat expansion correlates with copper binding properties. PLoS Pathog. 2009 Apr;5(4):e1000390.
  • Ilc G, Giachin G, Jaremko M, et al. NMR structure of the human prion protein with the pathological Q212P mutation reveals unique structural features. PLoS One. 2010 Jul 22;5(7):e11715.
  • D’Angelo P, Della Longa S, Arcovito A, et al. Effects of the pathological Q212P mutation on human prion protein non-octarepeat copper-binding site. Biochemistry. 2012 Aug 7;51(31):6068–6079.
  • Schilling KM, Tao L, Wu B, et al. Both N-terminal and C-Terminal histidine residues of the prion protein are essential for copper coordination and neuroprotective self-regulation. J Mol Biol. 2020 Jul 24;432(16):4408–4425.
  • Slapsak U, Salzano G, Amin L, et al. The N terminus of the prion protein mediates functional interactions with the Neuronal Cell Adhesion Molecule (NCAM) fibronectin domain. J Biol Chem. 2016 Oct 14;291(42):21857–21868.
  • Giachin G, Mai PT, Tran TH, et al. The non-octarepeat copper binding site of the prion protein is a key regulator of prion conversion. Sci Rep. 2015 Oct 20;5:15253.
  • Salzano G, Giachin G, Legname G. Structural consequences of copper binding to the prion protein. Cells. 2019 Jul 25;8(8). DOI:10.3390/cells8080770.
  • Salzano G, Brennich M, Mancini G, et al. Deciphering copper coordination in the mammalian prion protein amyloidogenic domain. Biophys J. 2020 Feb 4;118(3):676–687.
  • Wang LQ, Zhao K, Yuan HY, et al. Genetic prion disease-related mutation E196K displays a novel amyloid fibril structure revealed by cryo-EM. Sci Adv. 2021 Sep 10;7(37):eabg9676.
  • Kraus A, Hoyt F, Schwartz CL, et al. High-resolution structure and strain comparison of infectious mammalian prions. Mol Cell. 2021 Nov 4;81(21):4540–4551 e6.
  • Hoyt F, Standke HG, Artikis E, et al. Cryo-EM structure of anchorless RML prion reveals variations in shared motifs between distinct strains. Nat Commun. 2022 Jul 13;13(1):4005.
  • Manka SW, Zhang W, Wenborn A, et al. 2.7 A cryo-EM structure of ex vivo RML prion fibrils. Nat Commun. 2022 Jul 13;13(1):4004.
  • Hallinan GI, Ozcan KA, Hoq MR, et al. Cryo-EM structures of prion protein filaments from Gerstmann-Straussler-scheinker disease. Acta Neuropathol. 2022 Sep;144(3):509–520.
  • Caughey B, Standke HG, Artikis E, et al. Pathogenic prion structures at high resolution. PLoS Pathog. 2022 Jun;18(6):e1010594.
  • Artikis E, Kraus A, Caughey B. Structural biology of ex vivo mammalian prions. J Biol Chem. 2022 Jun 23;298(8):102181.